Indian Ginseng Market Report 2025

The Indian ginseng market size has grown strongly in recent years. It will grow from $0.86 billion in 2024 to $0.94 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth observed in the historical period can be attributed to a rising consumer awareness of herbal remedies, a growing demand for adaptogenic herbs, the expansion of organic and natural product markets, increased research and clinical studies, and government support for ayurvedic exports.

The Indian ginseng market size is expected to see strong growth in the next few years. It will grow to $1.29 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth projected for the forecast period is driven by the increasing awareness of herbal and ayurvedic products, a rising demand for natural health supplements, expanding pharmaceutical and nutraceutical applications, growth in the export of Indian ginseng products, and the rise of e-commerce and online sales of herbal products. Key trends during the forecast period include the integration of Indian ginseng in sports nutrition, strategic collaborations and partnerships, biotech advancements in cultivation, its adoption in weight management products, and its inclusion in traditional Chinese medicine.

The growing demand for natural and herbal products is expected to drive the expansion of the Indian ginseng market in the future. These products are made from plant-based or naturally sourced ingredients and are used for health, wellness, and beauty with minimal processing to maintain their benefits. The increasing demand for natural and herbal products is driven by rising consumer awareness of their health benefits, a growing preference for chemical-free ingredients, and the rise of sustainable and organic products across various industries. Indian ginseng (Ashwagandha) supports the demand for natural and herbal products by promoting stress relief, boosting energy, and enhancing overall wellness, in line with the increasing preference for plant-based, chemical-free solutions. For example, in September 2024, HerbalGram, a U.S.-based nonprofit, reported a 4.4% increase in annual sales of herbal dietary supplements in the U.S., rising from $12.018 billion in 2022 to $12.551 billion in 2023. This trend is driving the growth of the Indian ginseng market.

Key players in the Indian ginseng market are focusing on developing innovative products, such as organic gummies. These gummies are chewable, gelatin- or pectin-based candies made from organic ingredients, including organic sweeteners, natural flavors, and organic fruit extracts. For instance, in August 2023, Himalaya Wellness Company, an India-based pharmaceutical manufacturer, launched Himalaya's plant-based organic ashwagandha gummies. Made with clinically studied KSM-66 Ashwagandha root extract, these gummies help provide stress relief, enhance energy, and improve sleep quality. They are formulated to support adrenal function and balance cortisol levels. Free from gluten, dairy, corn, and soy, they are also USDA organic certified and non-GMO project verified, ensuring a clean and natural supplement option.

In April 2022, Kerry Group, an Ireland-based food company, acquired Natreon for an undisclosed amount. This acquisition allows Kerry Group to expand its ProActive Health portfolio by incorporating Natreon’s science-backed Ayurvedic botanical ingredients, thereby strengthening its presence in the health and wellness market. Natreon, Inc. is a U.S.-based nutraceutical company that specializes in providing Indian ginseng.

Major players in the indian ginseng market are Herbalife Nutrition, Kabir Lifesciences, Patanjali Ayurved, Botanic Healthcare, Apex International, Organic India Pvt. Ltd., Arjuna Natural Pvt. Ltd, Korea Ginseng Corp., Sabinsa Corporation, Kairali Ayurvedic Group, Himalaya Global Holdings, Baidyanath Group, Medikonda Nutrients, Amway India, Ixoreal Biomed, Uniray Lifesciences, Sandu Pharmaceuticals Ltd, PhytoLife Sciences, Zoic Pharmaceuticals, Charak Pharma Pvt. Ltd, Kshipra Biotech Private Limited, Greenwell Lifesciences, and Shree Sai Biotech.

Asia-Pacific was the largest region in the Indian ginseng market in 2024. The regions covered in Indian ginseng report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the Indian ginseng market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Indian ginseng, also known as withania somnifera or ashwagandha, is a medicinal herb used in Ayurveda for its adaptogenic and rejuvenating qualities. It is widely recognized for its ability to alleviate stress, boost cognitive function, enhance physical endurance, and support overall health.

The primary types of Indian ginseng include KSM-66, Sensoril, hydro-alcoholic Indian ginseng, and crude Indian ginseng. KSM-66 is a potent, full-spectrum ashwagandha extract known for its high bioavailability and clinically proven health benefits. It comes in various forms, such as powder, capsules, and liquid, and serves numerous functions, including improving stamina, enhancing immunity, promoting general well-being, reducing anxiety and stress, supporting brain health, increasing muscle strength, and offering other health benefits.

The indian ginseng market research report is one of a series of new reports that provides indian ginseng market statistics, including the indian ginseng industry global market size, regional shares, competitors with the indian ginseng market share, detailed indian ginseng market segments, market trends, and opportunities, and any further data you may need to thrive in the indian ginseng industry. This indian ginseng market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The Indian ginseng market consists of sales of capsules and tablets, liquid extracts, herbal teas, topical oils and creams, nutraceuticals, and supplements. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.